跳至主要内容
临床试验/NCT04815005
NCT04815005招募中不适用

HoFH, the International Clinical Collaborators - A Global HoFH Data-sharing Platform

University of Pennsylvania4 个研究点 分布在 3 个国家目标入组 1,000 人开始时间: 2017年1月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
4
主要终点
Number of participants entered into the database

研究概览

简要总结

Homozygous familial hypercholesterolemia (HoFH), a rare inherited disorder caused by bi-allelic mutations in the LDL Receptor pathway, is characterized by extremely elevated levels of low-density lipoprotein cholesterol (LDL-C) from birth and premature atherosclerotic cardiovascular disease (ASCVD). Our current knowledge about HoFH is disjointed and largely stems from relatively small case series and expert opinion. HICC (Homozygous FH International Clinical Collaborators) is a global consortium of clinicians who are contributing de-identified data of patients diagnosed with HoFH with the goal to advance our understanding of this rare disease.

详细描述

The HICC registry is an observational, multicenter, international registry collecting de-identified clinical and genetic information from patients with homozygous Familial Hypercholesterolemia (HoFH) worldwide.

Patients are eligible to be enrolled in the registry based on the diagnosis of HoFH by the treating clinician, irrespective of how the diagnosis was made. To generate up-to-date data reflecting current rather than historic practice, patients who died or were lost to follow-up prior to 2010 are excluded.

Anonymized data on demographics, type of HoFH diagnosis (clinical and/or based on the results of a genetic test), genetic results, (cardiovascular) medical history, relevant family history, physical examination, laboratory measurements, lipid lowering treatment and cardiovascular imaging are collected for 3 different time points: at diagnosis, at enrolment and at time of best lipid profile (if this is different from time at enrolment). Data are collected using pre-definite electronic case report forms to ensure uniformity of data collected. Primary analysis will be cross-sectional (e.g. based on country of residence, age, etc)

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Diagnosis of homozygous familial hypercholesterolemia (HoFH) clinically of genetically determined

排除标准

  • No diagnosis of HoFH

结局指标

主要结局

Number of participants entered into the database

时间窗: Through study completion, an average of 8 years

Number of study participants with homozygous familial hypercholesterolemia

次要结局

  • Untreated and treated LDL-C levels across world income regions(Through study completion, an average of 8 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验